Braeburn

Braeburn Inc. is a biopharmaceutical company dedicated to advancing solutions for individuals living with the severe and often life-threatening consequences of opioid use disorder (OUD). The company's core mission is to transform the management of OUD by developing and delivering a portfolio of next-generation therapies. These therapies are designed with individualized dosing regimens and innovative delivery options to better meet the needs of patients and healthcare providers. By focusing on a patient-centric approach, Braeburn aims to challenge the existing standards of care and address the significant unmet needs within the recovery community. The organization is committed to not only scientific innovation but also to breaking down the societal barriers and stigma that frequently complicate the treatment of addiction. This commitment extends to fostering partnerships with community organizations, healthcare professionals, and advocacy groups to create a more supportive and effective ecosystem for recovery.

Founded on the principles of integrity, respect, and perseverance, Braeburn operates with a deep sense of purpose, driven by the stories and needs of the patients it serves. The company actively engages with the community through various initiatives, including educational programs and volunteer work, to promote a greater understanding of OUD as a chronic brain disease. Braeburn's research and development efforts are focused on creating long-acting treatments that can help ensure medication adherence and improve patient outcomes. One of its key products is an extended-release injectable for moderate to severe OUD. Through its work, Braeburn aspires to create a world where every person with OUD has access to the best possible care and the opportunity to achieve their full potential, free from the burdens of addiction and societal judgment. The company upholds the highest ethical standards, emphasizing transparency and full compliance in all its operations to build trust with patients, partners, and the broader healthcare landscape.